Rokos Capital Management (UK)’s Caribou Biosciences CRBU Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-840,630	Closed	-$1.37M	–	83
2024 Q2	$1.37M	Hold	840,630	–	–	0.03%	95
2024 Q1	$4.3M	Hold	840,630	–	–	0.11%	81
2023 Q4	$4.8M	Sell	840,630 -1,907,509	-69%	-$9.43M	0.15%	57
2023 Q3	$13.3M	Hold	2,748,139	–	–	0.49%	66
2023 Q2	$11.2M	Hold	2,748,139	–	–	0.22%	53
2023 Q1	$14.1M	Hold	2,748,139	–	–	1.22%	23
2022 Q4	$17.3M	Buy	2,748,139 +840,630	+44%	+$7.48M	1.74%	26
2022 Q3	$20.8M	Hold	1,907,509	–	–	1.59%	33
2022 Q2	$10.6M	Buy	1,907,509 +1,058,175	+125%	+$8.09M	0.84%	50
2022 Q1	$7.9M	Buy	849,334 +278,975	+49%	+$2.94M	0.78%	40
2021 Q4	$8.6M	Buy	570,359 +220,386	+63%	+$4.29M	1.71%	21
2021 Q3	$8.2M	Buy	+349,973	New	+$8.56M	1.24%	38